nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—DRD1—attention deficit hyperactivity disorder	0.512	0.586	CbGaD
Ergoloid mesylate—DRD2—attention deficit hyperactivity disorder	0.361	0.413	CbGaD
Ergoloid mesylate—DRD1—Dopamine receptors—DRD5—attention deficit hyperactivity disorder	0.00913	0.0843	CbGpPWpGaD
Ergoloid mesylate—DRD2—Dopamine receptors—DRD5—attention deficit hyperactivity disorder	0.00689	0.0637	CbGpPWpGaD
Ergoloid mesylate—DRD1—Dopamine receptors—DRD3—attention deficit hyperactivity disorder	0.00498	0.046	CbGpPWpGaD
Ergoloid mesylate—DRD1—Dopamine receptors—DRD4—attention deficit hyperactivity disorder	0.00483	0.0446	CbGpPWpGaD
Ergoloid mesylate—DRD1—Dopamine receptors—DRD2—attention deficit hyperactivity disorder	0.0045	0.0416	CbGpPWpGaD
Ergoloid mesylate—DRD2—Dopamine receptors—DRD1—attention deficit hyperactivity disorder	0.00388	0.0359	CbGpPWpGaD
Ergoloid mesylate—DRD2—Dopamine receptors—DRD3—attention deficit hyperactivity disorder	0.00376	0.0347	CbGpPWpGaD
Ergoloid mesylate—DRD2—Dopamine receptors—DRD4—attention deficit hyperactivity disorder	0.00365	0.0337	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00206	0.019	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00202	0.0186	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00173	0.016	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0017	0.0157	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00155	0.0144	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00152	0.0141	CbGpPWpGaD
Ergoloid mesylate—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—attention deficit hyperactivity disorder	0.00132	0.0122	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00131	0.0121	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00128	0.0118	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00122	0.0113	CbGpPWpGaD
Ergoloid mesylate—Bromocriptine—DRD5—attention deficit hyperactivity disorder	0.00121	0.127	CrCbGaD
Ergoloid mesylate—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—attention deficit hyperactivity disorder	0.00119	0.011	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00118	0.0109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.00116	0.0107	CbGpPWpGaD
Ergoloid mesylate—Bromocriptine—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.119	CrCbGaD
Ergoloid mesylate—DRD1—forebrain—attention deficit hyperactivity disorder	0.00113	0.123	CbGeAlD
Ergoloid mesylate—Dihydroergotamine—HTR1B—attention deficit hyperactivity disorder	0.00111	0.116	CrCbGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0011	0.0102	CbGpPWpGaD
Ergoloid mesylate—DRD1—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.0011	0.0101	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00999	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00107	0.00987	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00949	CbGpPWpGaD
Ergoloid mesylate—DRD1—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.00102	0.00942	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000995	0.00919	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000993	0.00917	CbGpPWpGaD
Ergoloid mesylate—Dihydroergotamine—ADRA2A—attention deficit hyperactivity disorder	0.00098	0.103	CrCbGaD
Ergoloid mesylate—SLCO2B1—forebrain—attention deficit hyperactivity disorder	0.000939	0.102	CbGeAlD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000925	0.00854	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.000923	0.00852	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000909	0.0084	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000898	0.00829	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000888	0.0082	CbGpPWpGaD
Ergoloid mesylate—DRD2—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.000879	0.00812	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000858	0.00792	CbGpPWpGaD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000837	0.00773	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000831	0.00767	CbGpPWpGaD
Ergoloid mesylate—DRD2—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.000827	0.00764	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000817	0.00754	CbGpPWpGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000807	0.00745	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000776	0.00716	CbGpPWpGaD
Ergoloid mesylate—DRD1—midbrain—attention deficit hyperactivity disorder	0.000748	0.0809	CbGeAlD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000721	0.00666	CbGpPWpGaD
Ergoloid mesylate—DRD1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0007	0.00646	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000698	0.00645	CbGpPWpGaD
Ergoloid mesylate—DRD1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000697	0.00644	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000687	0.00634	CbGpPWpGaD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000678	0.00626	CbGpPWpGaD
Ergoloid mesylate—DRD2—forebrain—attention deficit hyperactivity disorder	0.00067	0.0724	CbGeAlD
Ergoloid mesylate—Bromocriptine—DRD4—attention deficit hyperactivity disorder	0.000619	0.0647	CrCbGaD
Ergoloid mesylate—DRD1—nervous system—attention deficit hyperactivity disorder	0.000615	0.0665	CbGeAlD
Ergoloid mesylate—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000592	0.0641	CbGeAlD
Ergoloid mesylate—DRD1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000586	0.00541	CbGpPWpGaD
Ergoloid mesylate—Ergotamine—HTR1B—attention deficit hyperactivity disorder	0.00057	0.0596	CrCbGaD
Ergoloid mesylate—Bromocriptine—HTR1B—attention deficit hyperactivity disorder	0.00055	0.0575	CrCbGaD
Ergoloid mesylate—Bromocriptine—DRD3—attention deficit hyperactivity disorder	0.000534	0.0558	CrCbGaD
Ergoloid mesylate—DRD2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000526	0.00486	CbGpPWpGaD
Ergoloid mesylate—Bromocriptine—DRD1—attention deficit hyperactivity disorder	0.000524	0.0548	CrCbGaD
Ergoloid mesylate—SLCO2B1—nervous system—attention deficit hyperactivity disorder	0.00051	0.0551	CbGeAlD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000505	0.00466	CbGpPWpGaD
Ergoloid mesylate—Ergotamine—ADRA2A—attention deficit hyperactivity disorder	0.000505	0.0528	CrCbGaD
Ergoloid mesylate—SLCO2B1—central nervous system—attention deficit hyperactivity disorder	0.000491	0.0531	CbGeAlD
Ergoloid mesylate—Bromocriptine—ADRA2A—attention deficit hyperactivity disorder	0.000487	0.0509	CrCbGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000482	0.00445	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000482	0.00445	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—cerebellum—attention deficit hyperactivity disorder	0.00048	0.0519	CbGeAlD
Ergoloid mesylate—DRD1—brain—attention deficit hyperactivity disorder	0.00047	0.0509	CbGeAlD
Ergoloid mesylate—DRD2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000442	0.00409	CbGpPWpGaD
Ergoloid mesylate—DRD2—midbrain—attention deficit hyperactivity disorder	0.000442	0.0478	CbGeAlD
Ergoloid mesylate—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000403	0.00372	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000397	0.00367	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—brain—attention deficit hyperactivity disorder	0.00039	0.0421	CbGeAlD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000389	0.0036	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000387	0.00357	CbGpPWpGaD
Ergoloid mesylate—Ergotamine—DRD2—attention deficit hyperactivity disorder	0.000383	0.0401	CrCbGaD
Ergoloid mesylate—Bromocriptine—DRD2—attention deficit hyperactivity disorder	0.000369	0.0386	CrCbGaD
Ergoloid mesylate—DRD2—nervous system—attention deficit hyperactivity disorder	0.000363	0.0393	CbGeAlD
Ergoloid mesylate—DRD2—central nervous system—attention deficit hyperactivity disorder	0.00035	0.0378	CbGeAlD
Ergoloid mesylate—SLCO2B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000346	0.00319	CbGpPWpGaD
Ergoloid mesylate—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000342	0.037	CbGeAlD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00034	0.00314	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000335	0.00309	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000334	0.00308	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000323	0.00299	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0003	0.00277	CbGpPWpGaD
Ergoloid mesylate—Ergotamine—HTR2A—attention deficit hyperactivity disorder	0.000296	0.031	CrCbGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000294	0.00271	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000292	0.0027	CbGpPWpGaD
Ergoloid mesylate—Bromocriptine—HTR2A—attention deficit hyperactivity disorder	0.000285	0.0299	CrCbGaD
Ergoloid mesylate—DRD2—brain—attention deficit hyperactivity disorder	0.000278	0.03	CbGeAlD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00027	0.00249	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000268	0.00247	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000259	0.00239	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000259	0.00239	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000257	0.00237	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000254	0.00235	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000253	0.00234	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000252	0.00233	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000252	0.00233	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000236	0.00218	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000235	0.00217	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000231	0.00214	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000222	0.024	CbGeAlD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00022	0.00203	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000218	0.00202	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000214	0.0231	CbGeAlD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000212	0.00196	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000209	0.00193	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000206	0.0019	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000204	0.00188	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000202	0.00187	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000202	0.00187	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000202	0.00187	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000198	0.00183	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000196	0.00181	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000196	0.00181	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000192	0.00177	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000192	0.00177	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000192	0.00177	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00019	0.00176	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000182	0.00168	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000179	0.00165	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000178	0.00164	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000177	0.00163	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000176	0.00163	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000176	0.00162	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000175	0.00161	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000173	0.0016	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00017	0.00157	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000168	0.00155	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000166	0.00153	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000165	0.00152	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000165	0.00152	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00016	0.00148	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000158	0.00146	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000156	0.00144	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000154	0.00142	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000153	0.00141	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00015	0.00138	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000147	0.00135	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000144	0.00133	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000142	0.00131	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000139	0.00128	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000137	0.00127	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000136	0.00126	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000135	0.00125	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000135	0.00124	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000135	0.00124	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000133	0.00123	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000133	0.00123	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000133	0.00123	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00013	0.0012	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000125	0.00116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000124	0.00114	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000117	0.00108	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000116	0.00107	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000115	0.00106	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000111	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000108	0.001	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000108	0.000998	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000105	0.000966	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.00095	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000102	0.000938	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000102	0.000938	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0001	0.000928	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	9.95e-05	0.000919	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.84e-05	0.000909	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	9.15e-05	0.000845	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	9.04e-05	0.000834	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.85e-05	0.000817	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.78e-05	0.000811	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	8.7e-05	0.000804	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.7e-05	0.000804	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	8.7e-05	0.000803	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	7.9e-05	0.000729	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.86e-05	0.000726	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.83e-05	0.000723	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.7e-05	0.000711	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.7e-05	0.000711	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.6e-05	0.000702	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.55e-05	0.000697	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.51e-05	0.000694	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.11e-05	0.000657	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.08e-05	0.000654	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.99e-05	0.000646	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.91e-05	0.000638	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.9e-05	0.000638	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.82e-05	0.00063	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.63e-05	0.000612	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.62e-05	0.000611	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.57e-05	0.000607	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	6.57e-05	0.000607	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.57e-05	0.000606	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.53e-05	0.000603	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.43e-05	0.000594	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.1e-05	0.000564	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.96e-05	0.000551	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.93e-05	0.000548	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.91e-05	0.000546	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.81e-05	0.000537	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.81e-05	0.000537	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.74e-05	0.00053	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.7e-05	0.000527	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.54e-05	0.000512	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.37e-05	0.000496	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.34e-05	0.000493	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.28e-05	0.000487	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.21e-05	0.000481	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.96e-05	0.000458	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.67e-05	0.000431	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.5e-05	0.000416	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.2e-05	0.000388	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.13e-05	0.000381	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.08e-05	0.000377	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.03e-05	0.000372	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.8e-05	0.000351	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.74e-05	0.000346	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.52e-05	0.000325	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.4e-05	0.000314	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.27e-05	0.000302	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.17e-05	0.000293	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.12e-05	0.000288	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.08e-05	0.000284	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.71e-05	0.00025	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.66e-05	0.000246	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.01e-05	0.000186	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.87e-05	0.000173	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.87e-05	0.000173	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.84e-05	0.00017	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.71e-05	0.000158	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.49e-05	0.000138	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.41e-05	0.00013	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.13e-05	0.000105	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.12e-05	0.000104	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.06e-05	9.83e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	4.85e-06	4.48e-05	CbGpPWpGaD
